Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new history entry on 2026-07-06 updates the Study Status to Completed and notes that no participants are being recruited; the 2026-02-25 entry was removed from the history.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page's footer revision label was updated to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check25 days agoChange DetectedA new revision entry v3.6.2 appears in the record history, and the older v3.6.0 entry is removed. This documents a backend/platform update rather than changes to study data or on-page text.SummaryDifference0.0%

- Check40 days agoChange DetectedThe latest record version indicates recruitment has ended, and the revision metadata shows a new version (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

- Check47 days agoChange DetectedA new Revision: v3.5.5 is added and the previous Revision: v3.5.4 is removed from the history, updating the page’s revision tag. This administrative metadata change does not affect study content, results, or user-facing functionality.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a newer site build.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.